Uždaroji akcinė bendrovė "CHEMI PHARM GROUP" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo dataFinancial statetment report
Price: €9.90
Premium users: 1.00 credit
Premium users: 1.00 credit
Indicator |
---|
Turnover (€) |
Sales per employee (€) |
Profit before tax (€) |
Net Profit (€) |
Profit per employee (€) |
Total profitability (%) |
Net profitability (%) |
Equity (€) |
Amounts Payable And Liabilities (€) |
Non-current Assets (€) |
CurrentAssets (€) |
Working capital requirement |
Debt-to-equity ratio |
EBITDA margin (%) |
EBITDA (€) |
EBIT margin (%) |
EBIT (€) |
2021 |
---|
625,708 |
112,134 |
134,490 |
114,019 |
20,434 |
38.03 |
18.22 |
368,414 |
103,468 |
31,082 |
440,490 |
2022 |
---|
606,658 |
101,110 |
27,732 |
19,728 |
3,288 |
34.76 |
3.25 |
311,671 |
26,284 |
30,403 |
307,552 |
2023 |
---|
598,399 |
99,733 |
52,801 |
44,195 |
7,366 |
33.57 |
7.39 |
300,441 |
39,937 |
24,216 |
316,162 |
Register and
explore Okredo data2023 |
---|
598,399 |
99,733 |
52,801 |
44,195 |
7,366 |
33.57 |
7.39 |
300,441 |
39,937 |
24,216 |
316,162 |
Register and
explore Okredo data2023
Turnover (€)
598,399 €-1 % *
Sales per employee (€)
99,733 €-1 % *
Profit before tax (€)
52,801 €90 % *
Net Profit (€)
44,195 €124 % *
Profit per employee (€)
7,366 €124 % *
Total profitability (%)
33.57 %-3.42 % *
Net profitability (%)
7.39 %127.38 % *
Equity (€)
300,441 €-4 % *
Amounts Payable And Liabilities (€)
39,937 €52 % *
Non-current Assets (€)
24,216 €-20 % *
CurrentAssets (€)
316,162 €3 % *